National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Extrahepatic Bile Duct Cancer Treatment (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 05/16/2008



Purpose of This PDQ Summary






General Information







Cellular Classification






Stage Information






Localized Extrahepatic Bile Duct Cancer






Unresectable Extrahepatic Bile Duct Cancer






Recurrent Extrahepatic Bile Duct Cancer






Get More Information From NCI






Changes to This Summary (05/16/2008)






More Information



Page Options
Print This Page  Print This Page
Print This Document  Print Entire Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

New Study of Targeted Therapies for Breast Cancer

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Cellular Classification

The term, cholangiocarcinoma, is sometimes used to refer to any primary cancer of the biliary system; however, its use is often restricted to intrahepatic tumors and, therefore, it is not included in this summary. Adenocarcinomas are the most common type of extrahepatic bile duct cancers. The histologic types are listed below:[1]

  • Carcinoma in situ.
  • Adenocarcinoma, not otherwise specified (NOS).
  • Adenocarcinoma, intestinal type.
  • Mucinous adenocarcinoma.
  • Clear cell adenocarcinoma.
  • Signet-ring cell carcinoma.
  • Adenosquamous carcinoma.
  • Squamous cell carcinoma.
  • Small cell (oat cell) carcinoma.
  • Undifferentiated carcinoma.
    • Spindle and giant cell types.
    • Small cell types.
  • Papillomatosis.
  • Papillary carcinoma, noninvasive.
  • Papillary carcinoma, invasive.
  • Carcinoma, NOS.

Malignant mesenchymal tumors, although rare, include the following:

  • Embryonal rhabdomyosarcoma.
  • Leiomyosarcoma.
  • Malignant fibrous histiocytoma.

References

  1. Extrahepatic bile ducts. In: American Joint Committee on Cancer.: AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer, 2002, pp 145-150. 

Back to TopBack to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov